Impax Global Equity Opportunities Fund Class S

Reference Data

ISIN IE00BJKWZK37
Valor Number 48073266
Bloomberg Global ID
Fund Name Impax Global Equity Opportunities Fund Class S
Fund Provider Impax Asset Management Limited London, United Kingdom
Phone: +44 20 7432 2609
E-Mail: info@impax.co.uk
Web: www.impax.co.uk
Fund Provider Impax Asset Management Limited
Representative in Switzerland CACEIS Bank, Montrouge, Zurich Branch / Switzerland
Zurich
Phone: +41 44 405 97 00
Distributor(s) JP Morgan (Suisse) S.A.
Genève
Phone: +41 22 744 19 00
Asset Class Equities
EFC Category
Distribution Policy Distribution
Home Country Ireland
Issuing Condition Combination of issuing commission charged by the fund management company and transaction fee charged by the fund
Redemption Condition The fund does not charge any redemption commission and/or fees (units are redeemed at the NAV)
Investment Strategy *** The Fund’s investment objective is to generate long term capital growth through an actively managed portfolio of equities from issuers across global equity markets.
Peculiarities

Fund Prices

Current Price * 1.29 GBP 13.09.2024
Previous Price * 1.28 GBP 12.09.2024
52 Week High * 1.29 GBP 13.09.2024
52 Week Low * 1.05 GBP 27.10.2023
NAV * 1.29 GBP 13.09.2024
Issue Price *
Redemption Price *
Closing Price *
Indicative Minimum Price
Fund Assets *** 1,104,175,730
Unit/Share Assets *** 77,854,649
Trading Information SIX

Performance

YTD Performance +10.07% 29.12.2023
13.09.2024
YTD Performance (in CHF) +14.49% 29.12.2023
13.09.2024
1 month +3.37% 13.08.2024
13.09.2024
3 months +3.20% 13.06.2024
13.09.2024
6 months +4.12% 13.03.2024
13.09.2024
1 year +14.77% 13.09.2023
13.09.2024
2 years +19.44% 13.09.2022
13.09.2024
3 years +15.28% 13.09.2021
13.09.2024
5 years +29.00% 05.05.2021
13.09.2024

Tax Data

Equity Participation Rate in %
Share of Total Fund Assets in %
Real Estate Rate in %
ADDI
ADDI Date

Top 10 Holdings ***

Microsoft Corp 4.22%
Alcon Inc 4.02%
Mastercard Inc Class A 3.94%
Linde PLC 3.81%
Thermo Fisher Scientific Inc 3.49%
IQVIA Holdings Inc 3.41%
Boston Scientific Corp 3.34%
Cintas Corp 3.25%
Schneider Electric SE 3.20%
Marsh & McLennan Companies Inc 3.08%
Last data update 31.08.2024

Cost / Risk

TER
TER date
Performance Fee ***
PTR
Max. Management Fee *** 0.40%
Ongoing Charges *** 0.49%
SRRI ***
SRRI date *** 31.08.2024

ESG Fund Ratings

Low Carbon Designation ***
ESG Rating Overall ***
ESG Rating Corporate ***
ESG Rating Sovereign ***
% AuM H&S Controversies ***

Breakdowns

Countries ***

Stock Sectors ***

Bond Sectors ***

ESG Carbon Metrics

Avg Carbon Risk Score ***
Avg Carbon Risk Cat Avg ***
% AuM Covered Carbon ***
Avg Fossil Fuel Exposure ***
Fossil Fuel Cat Avg ***

ESG Strategy

Strategy Level 1 ***
Strategy Level 2 ***
Strategy Level 3 ***
Exclusions Level 1 ***
Exclusions Level 2 ***

* NAV / Issue Price exclusive commissions, for listed funds NAV or closing price
** Calculation of interim profit followed § 9 Satz 2 InvStG
*** Data source: Morningstar (Data is based on the rescaled long position of the holdings)